Inadequate relief of postoperative pain remains a major clinical problem. i-3 The traditional p.r.n. intramuscular injection of narcotics such as morphine and pethidine frequently gives only poor analgesia after major surgery.i,] However, greater success can be achieved when these same drugs are administered in ways that better fit their particular pharmacokinetic profiles, best results being attained with continuous intravenous infusion. 4 ,5 Alternative and less complicated approaches employ other narcotics that have extended durations of action due to a prolonged elimination half-life (methadone), 6 or slow dissociation of the drug-receptor complex (buprenorphine). 7 Buprenorphine is a product of research into narcotic analgesics lacking the major sideeffects of respiratory depression and addiction. It is a highly lipophilic oripavine derivative of thebaine with mixed agonist/antagonist properties, and is structurally similar to morphine, enjoying a similar efficacy as a < 50 kg 50-60 kg 60-70 kg > 70 kg 8 .
1O although being 25-50 or more times as potent. 8·11 Various studies have demonstrated an extended duration of action compared with traditional opioids. [8] [9] [10] This may allow six-to eight-hourly administration for the relief of acute pain with fewer periods of suboptimal analgesia between doses. A dose of 0.3 to 0.6 mg lO .
12 is usually recommended for postoperative analgesia. Other reports have concerned its use in chronic pain 13, 14 and in supplementing general anaesthesia. 15 This study was designed to enable comparison of the efficacy, duration of action, and side-effects of morphine and buprenorphine administered intravenously at the start of peritoneal closure in patients undergoing elective cholecystectomy or abdominal hysterectomy, both operations usually being associated with postoperative pain sufficiently severe to necessitate the administration of narcotics. 16 
PATIENTS AND METHODS
The study was approved by the Hospital Medical Advisory and Ethics Committee. Eighty patients having elective cholecystectomy or abdominal hysterectomy received an intravenous bolus of either buprenorphine or morphine at the start of peritoneal closure. The dose regimen (Table 1) Table 2 .
The trial was randomised and double-blind. Assessment of pain score, drowsiness, blood pressure, pulse rate, respiratory rate, nausea, vomiting and other side-effects was made at 30 and 60 minutes, and then hourly until 8 hours after narcotic administration. All pain score and drowsiness observations were made by the author. The pain scoring technique (Table 3) incorporated subjective and objective components and is partially based on that of Stapleton, Austin and Mather. 5 A 'Drowsiness Score' was assigned at each interval (see Table  3 ). Attempts to obtain PEFR (peak expiratory flowrate) recordings during each pain assessment were abandoned early in the trial as patients were frequently too obtunded to cooperate early in the postoperative period. When the ward nursing staff felt that a patient had pain that warranted further narcotic administration, he or she was withdrawn from the trial, and a total pain score of 4 assigned for the remainder of the assessment period.
Statistical analysis of results was undertaken where appropriate, using Student's t-test, and Fisher's Exact Test and Chi-squared for the contingency tables.
RESULTS
All patients were in ASA classes 1 or 2, and were matched for age and mass for both surgical procedure undertaken and drug administered. The dose of buprenorphine given ranged from 4.0 to 6.3 /Ag/kg. Pain scores the distribution of scores for each patient group It was originally intended to combine the is presented separately (see Figures 1 and 2) . surgical groups for analysis of pain score data. The results show that the distribution of pain However, patients undergoing abdominal scores favoured buprenorphine marginally at hysterectomy had a different pattern of pain most intervals after hysterectomy, but relief from those having cholecystectomy, so markedly at all intervals after cholecystectomy. Most patients were moderately to very drowsy at the time of the first observation, and somewhat less so at one hour. However, no difficulty was experienced in assigning a value to the subjective component of the pain score at these times.
Withdrawal because of pain
The cumulative numbers of patients withdrawn from the study because of pain were less for buprenorphine than for morphine at all intervals studied in the cholecystectomy group, and at most intervals in the hysterectomy group ( Figure 3 , Table 4 ). The differences were statistically significant at all times analysed in
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.c the former group but failed to achieve significance in the latter. Analysis of the combined surgical groups showed differences at various levels of significance except at the 7-8 hour interval.
Drowsiness
Most patients were drowsy in the first hour of the study (see Figure 4) . Those not withdrawn from the study because of pain were more likely to be drowsy late in the observation period if they had received buprenorphine, although this was only occasionally of clinical significance. One patient was extremely drowsy for -five hours after receiving buprenorphine. When her respiratory rate fell to 9 breaths per minute, naloxone 0.4 mg was administered intravenously, with prompt return of alertness. No patients received analeptic drugs.
Blood pressure and pulse rate
Mean systolic blood pressure was higher at all intervals in patients who received morphine, as was mean diastolic pressure at all intervals except at four hours. Mean pulse rates were marginally higher in the buprenorphine group except at 30 minutes and one hour when they were slightly lower. The differences had no clinical or statistical significance.
Respiratory rate
The mean respiratory rates were lower at all intervals in the buprenorphine group but the differences were not clinically or statistically significant (see Figure 5 ). One alert female patient (age 58 years, mass 65 kg) had a respiratory rate of 8 breaths per minute 30 minutes after receiving buprenorphine. Because all other signs were acceptable, no treatment was given, the respiratory rate returning to 12 breaths per minute after a further 30 minutes. A second elderly woman (age 61 years, mass 55 kg) who had a respiratory rate of 9 breaths per minute in conjunction with extreme drowsiness, but no impairment of cardiovascular function, had an increase in respiratory rate to 16 breaths per minute after naloxone was given. 
Nausea, vomiting and other side-effects
Similar numbers of patients in each drug group experienced nausea (Table 5) . Vomiting occurred more frequently with buprenorphine, but not significantly so (p = 0.055: Fisher's Exact Test). Other side-effects were much less common and were clinically of a minor nature.
DISCUSSION
Analysis of the results for the combined surgical groups verifies that with the doses studied and the potency ratio assumed, patients receiving buprenorphine achieved better analgesia of longer duration than those receiving morphine. This was expressed as a tendency to lower pain scores at each interval studied, and in the lower progressive numbers of patients withdrawn from the trial because of pain, and confirms the findings of others 9 ,1O who used similar methodology to compare these two drugs. Based on these criteria the extended duration of buprenorphine with respect to morphine achieved statistical significance, and demonstrates that 6-8 hourly administration may be feasible, in contrast to the more usual 3-4 hourly injection of the traditional narcotics.
Despite the high incidence of drowsiness at 30, and to a lesser extent 60 minutes, a large majority of patients had clinically acceptable pain relief at these times, verifying that both drugs were initially efficacious when given in this way. However, the tendency for the buprenorphine group to have lower initial pain scores and respiratory rates may indicate a potency ratio of more than the 33: 1 assumed, and is in agreement with others. 8, 9 The bedside decision to administer further analgesics and withdraw the patient from the trial, was based on an objective assessment of the patient's demeanour and subjective appraisal of his own pain. This of course is the basis of the p. r. n. approach to the administration of postoperative analgesics, and the pain-scoring technique gave cognisance to this fact. An initial attempt to assess pain subjectively with visual analogue scoring, which would have facilitated statistical analysis, was unsuccessful as patients were usually too drowsy to fully co-operate early in the postoperative period. This experience has been reported elsewhere. 5 The original intention had been to combine the hysterectomy and cholecystectomy patients for analysis of the pain scores but it became apparent early in the study that the groups had different postoperative pain responses.
Hysterectomy patients ascribed higher values to the subjective component of the pain score. This is reflected in their tendency to have higher initial pain scores than the cholecystectomy patients and in their high early withdrawal rate in both drug groups. It was interesting that intravenous increments of narcotic given to some of the withdrawn patients did not result in a reduction of the subjective pain scores, even where obtunding of consciousness or slowing of the respiratory rate occurred. With the cholecystectomy patients, those receiving buprenorphine tended to have lower initial pain scores. This could indicate, as noted above, that the potency ratio selected for this study underestimated buprenorphine. Further work with different ratios could answer this possibility. Alternatively, a direct effect of morphine on the bile ducts or sphincter could have caused visceral pain which would have been reflected in higher pain scores. However, the subjective component of the pain score (Table 3 ) was designed to enable recognition of this type of pain, which was not seen in any of the cholecystectomy patients.
Patients having upper abdominal surgery are usually thought to have more postoperative pain than those having lower abdominal surgery. 16 With the pain-scoring methodology used in this study, the converse was the case, similar findings having previously been reported by others. 16,17 While it is possible that abdominal hysterectomy was in this study a more painful operation than cholecystectomy, the degree of age and mass matching, and the tendency for both groups of patients to have subcostal or transverse incisions involving relatively few dermatomes, make this supposition difficult to prove. Other factors may also be involved, including those personality traits reported to be associated with more postoperative pain, such as the 'extroversion'18 and 'neuroticism' 18,19 components of the Eysenck Personality Inventory (EPI).20 Gibbs l7 reported such differences between gynaecology patients and general surgical patients in his study comparing buprenorphine and pethidine for postoperative analgesia.
Others have reported better results in patients having abdominal hysterectomy using buprenorphine in this dose range. 8 ,12 A different pain-scoring methodology may perhaps have enabled clearer differentiation in the hysterectomy group between the analgesic effects of the two drugs.
Most patients were very drowsy early in the observation period. This was anticipated with an anaesthetic sequence that combined diazepam premedication with volatile supplementation and the administration of a narcotic late in the operative procedure. The more usual administration of a narcotic as a premedicant or early in the operation could be expected to lessen this problem. Drowsiness was more common late after buprenorphine in this study but was not a problem of clinical significance. Other studies have shown that drowsiness is more common with i:ruprenorphine than with morphine, occurring in 40-75070 of patients,8,11 although a third found a similar incidence. 9
Two patients had a respiratory rate of less than 10 breaths per minute in the period following administration of buprenorphine. In one very drowsy patient, in which this was felt to be of clinical importance, naloxone reversed the slow respiratory rate. The monitored release program conducted by the manufacturer (data on file, Reckitt and Colman) reported that 1.1 % of 9,366 patients given buprenorphine had a respiratory rate of 10/minute or less at some time after administration. Fifty-four of these patients were given reversal agents, most commonly doxapram. While naloxone may be an adequate antagonist in some instances, its effectiveness cannot be relied upon. 21 Doxapram may also be effective but the usual supportive methods must be available. 21 Respiratory depression is a potentially lethal complication of narcotic administration. While the mixed agonist/antagonists are said to display limitation of respiratory depressant effects with increasing dose, it is possible that in a larger series with patients older than those in this study serious respiratory depression could occur.
More of the buprenorphine patients experienced nausea and vomiting in this series than in others,8,9 where the incidence with both narcotics was similar, and much less. In clinical practice the inclusion of drugs with anti-emetic properties in the anaesthetic sequence would be expected to reduce the incidence of this sideeffect. The other side-effects noted were not of clinical significance.
The achievement of prolonged postoperative analgesia with conventional narcotics requires the sustaining of blood levels that exceed a minimum analgesic concentration. It has been demonstrated that intramuscular administration leads to varying blood concentrations in different patients at the same time,22 and in the same patient at different times. Various pharmacokinetic mechanisms are responsible. Even with intravenous infusion, the technique that best achieves steady blood levels, inter-and intrapatient variation in analgesic threshold l8 makes the provision of good postoperative analgesia difficult. An analgesic that could be given as a single dose early in the operative or postoperative course without fear of respiratory depression, and in the expectation of a prolonged duration of action, would enjoy logistical advantages. Buprenorphine in the dose range 4-6 Jig/kg has been found by others to be effective in this mode. 8 ,12 It has been suggested that its efficacy as an analgesic, and duration of action may be further facilitated by increasing the dose to 8 Jig/kgl7 although this has not been confirmed by the author in patients undergoing hysterectomy.
Animal and human studies l4 suggest a lesser dependence liability for buprenorphine, and a direct addiction study in man produced only a delayed and moderate physical withdrawal syndrome. 12 However, drug dependence is rarely a problem in the context of the relief of severe postoperative pain.
Buprenorphine has proved in this study to be at least as efficacious as morphine in the management of severe postoperative pain. A single intraoperative injection of 4-6 Jig/kg provided analgesia for a statistically longer time than a comparable dose of morphine. This should enable patients to experience fewer painful interludes in the postoperative course. As always, best results will be achieved when treatment is individualised.
